PRIMO study Archives

$ASH 2019: PRIMO Study Evaluates Duvelisib in Relapsed or Refractory Peripheral T-Cell Lymphoma$

Peter Hofland, Ph.D - December 7, 2019

Editorial Team - June 1, 2023

Editorial Team - June 1, 2023

Rachana Pradhan - May 31, 2023

Ronnie Cohen - May 30, 2023

Equify Health Receives $1 Million Grant to Launch Transformative... May 31, 2023
Workshop Will Train Medical Providers to Deliver Inclusive Care to Minority Patients(PRWeb May 31, 2023)Read the full story at https://www.prweb.com/releases/2023/5/prweb19355613.htm
University Cancer & Blood Center recognizes importance of clinical... May 25, 2023
UCBC offers access to latest, greatest cancer treatment therapies(PRWeb May 25, 2023)Read the full story at https://www.prweb.com/releases/university_cancer_blood_center_recognizes_importance_of_clinical_trials_during_national_cancer_research_month/prweb19358186.htm
Building in Solutions for Anticipated Challenges in CAR T Development... May 25, 2023
In this free webinar, learn how to increase enrollment in CAR T trials through site selection, site support and thoughtful communication channels. Attendees will learn how to incorporate enrollment...(PRWeb May 25, 2023)Read the full story at https://www.prweb.com/releases/building_in_solutions_for_anticipated_challenges_in_car_t_development_programs_upcoming_webinar_hosted_by_xtalks/prweb19357976.htm

Tag: PRIMO study